Nyxoah (NYXH.BR) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Equipment · Belgium · ISIN BE0974358906
Price
0.83 EUR
Market cap
84.43 m EUR
P/E (2025)
–
P/S (2025)
8.43
Dividend yield
0.00 %
Net margin
-899.05 %
Return on equity (ROE)
-183.36 %
Return on assets (ROA)
-76.04 %
Nyxoah financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 4.52 m EUR | 10.02 m EUR |
| Gross profit | 2.97 m EUR | 6.33 m EUR |
| Operating income | -58.81 m EUR | -82.94 m EUR |
| EBIT | -55.55 m EUR | -87.23 m EUR |
| Net income | -59.24 m EUR | -90.09 m EUR |
| Diluted EPS – continuing operations | -1.58 EUR | -2.09 EUR |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Nyxoah
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
More stocks
- Vaxart, Inc. (VXRT)
- Nonthavej Hospital Public Company Limited (NTV.BK)
- iHeartMedia, Inc. (IHRT)
- Byrna Technologies Inc. (BYRN)
- Awilco LNG ASA (ALNG.OL)
- Fifth District Bancorp, Inc. (FDSB)
- PT Satu Visi Putra Tbk (VISI.JK)
- Kencoa Aerospace Corporation (274090.KQ)
- Endeavor Bank (EDVR)
- Twinhead International Corp (2364.TW)
- Ruby Tech (8048.TWO)
- Hanshin Const (004960.KS)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.